Who Just RaisedGaithersburg, MD · Health Care · Form D filed Aug 6, 2026
Cerium Pharmaceuticals, Inc. raised $750K
Cerium Pharmaceuticals, Inc. is a pharmaceutical company based in Gaithersburg, Maryland. In a Form D filed with the SEC on August 6, 2026, it reported raising $750,000 from 4 investors as part of an offering of up to $2,544,000. The first sale in the offering took place on May 22, 2026.
- 4th Form D since 2016. Earlier new notices: Jul 30, 2021 · May 25, 2021 · Jun 27, 2016. All filings on EDGAR
- Still raising. $1.8M of the $2.5M offering was still unsold at filing.
$11.6M raised since 2020
3 Form D offerings, as reported to the SEC, the first in May 25, 2021. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Aug 6, 2026 | $750K | $2.5M | 4 |
| Jul 30, 2021 | $8.9M | $10.1M | 5 |
| May 25, 2021 | $1.9M | $1.9M | 9 |
Lead score
11 out of 100
still raising
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Amount raised
- $750,000
- Offering size
- $2,544,000
- Investors so far
- 4
- First sale
- May 22, 2026
- Securities offered
- Equity
- Exemption claimed
- Rule 506(b)
- Industry
- Pharmaceuticals
- Headquarters
- Gaithersburg, Maryland
- Incorporated
- Delaware
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $750,000 | $2,544,000 | 4 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Aug 3, 2026 · Health Care funding in Maryland · August 2026 funding report
Similar raises
ColoWatch, Inc.
Gaithersburg, MD · filed Oct 8
Virtual colonoscopy screening with no sedation, standardized protocols, secure cloud delivery, advanced 3D visualization, and expert radiologist interpretation.
First Form DStill raising
Georgiamune, Inc.
Gaithersburg, MD · filed Aug 17
Regulating signaling pathways to restore immune homeostasis to fight cancer and autoimmune diseases.
First Form DStill raising
Kaigene, Inc.
Rockville, MD · filed Oct 142nd Form D since 2022Still raising
Templar Nova, Inc.
Rockville, MD · filed Oct 7First Form D
Monocacy Therapeutics Inc.
Monrovia, MD · filed Oct 75th Form D since 2026
Seraxis Holdings, Inc.
Germantown, MD · filed Sep 24
Seraxis is a private biotechnology company that has developed a novel cell and immune-evasion technology with the goal to reverse Type 1 Diabetes.
2nd Form D since 2021
Aromha, Inc.
Potomac, MD · filed Sep 243rd Form D since 2025
Uvantis Therapeutics, Inc.
Columbia, MD · filed Sep 23First Form DStill raising